291 related articles for article (PubMed ID: 8808477)
1. [Vancomycin and teicoplanin: differential aspects].
Cobo J
Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):600-10. PubMed ID: 8808477
[No Abstract] [Full Text] [Related]
2. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
Bouza E; Rodríguez-Créixems M; Muñoz P
Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
[No Abstract] [Full Text] [Related]
3. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
Lefort A; Arthur M; Depardieu F; Chau F; Pouzet C; Courvalin P; Fantin B
J Infect Dis; 2004 Jan; 189(1):90-7. PubMed ID: 14702158
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
[TBL] [Abstract][Full Text] [Related]
5. [Streptogramins and glycopeptides].
Tsuji A
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():360-6. PubMed ID: 17455646
[No Abstract] [Full Text] [Related]
6. [Enterococcal endocarditis, a model of therapeutic difficulty].
Fernández Guerrero ML; Núñez García A
Rev Clin Esp; 1995 Oct; 195 Suppl 4():41-5. PubMed ID: 9441316
[No Abstract] [Full Text] [Related]
7. Teicoplanin in the therapy of gram-positive infections: an open non-randomized study.
De Lalla F; Rinaldi E; Santoro D; Rizzardini G; Martello P; Guaglianone MH
J Chemother; 1989 Jul; 1(4 Suppl):719-21. PubMed ID: 16312606
[No Abstract] [Full Text] [Related]
8. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
[TBL] [Abstract][Full Text] [Related]
9. Teicoplanin.
Salaria M
Indian Pediatr; 2001 Apr; 38(4):372-5. PubMed ID: 11313506
[No Abstract] [Full Text] [Related]
10. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.
Rybak MJ; Bailey EM; Warbasse LH
Antimicrob Agents Chemother; 1992 Jun; 36(6):1204-7. PubMed ID: 1384423
[TBL] [Abstract][Full Text] [Related]
11. [Glycopeptides (vancomycin, teicoplanin)--their place in the antibacterial therapy of patients in a high-risk group].
Beloborodova NV
Anesteziol Reanimatol; 1998; (4):23-7. PubMed ID: 9770813
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological considerations in the economic evaluation of glycopeptides].
García-Quetglas E; Sádaba B; Honorato J
Rev Clin Esp; 1997 Sep; 197 Suppl 2():68-73. PubMed ID: 9441326
[No Abstract] [Full Text] [Related]
14. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
15. [Teicoplanin. New treatment potentials for gram-positive infections in the hospital].
Iakovlev SV
Antibiot Khimioter; 1999; 44(2):3-7. PubMed ID: 10202550
[No Abstract] [Full Text] [Related]
16. [Enterococcal resistance to glycopeptide antibiotics].
Cercendado Mansilla E
Rev Clin Esp; 1995 Oct; 195 Suppl 4():22-7. PubMed ID: 9441312
[No Abstract] [Full Text] [Related]
17. [Enterococcus faecalis endocarditis successfully treated with daptomycin].
Bonnet E
Med Mal Infect; 2008 Dec; 38 Spec No 2():4-6. PubMed ID: 19185201
[No Abstract] [Full Text] [Related]
18. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
[No Abstract] [Full Text] [Related]
19. [Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin].
Waldvogel F
Schweiz Med Wochenschr; 1993 Dec; 123(50):2353-6. PubMed ID: 8272810
[No Abstract] [Full Text] [Related]
20. Dalbavancin: a review for dermatologists.
Scheinfeld N
Dermatol Online J; 2006 May; 12(4):6. PubMed ID: 17083861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
